MIDROC Group

MIDROC Group is a diversified international conglomerate with a significant presence in the pharmaceutical and healthcare sectors, particularly through its operations in Ethiopia. The group's life sciences arm, MIDROC Pharmaceuticals, is a major manufacturer of essential medicines, including antibiotics, analgesics, and gastrointestinal drugs, aimed at improving healthcare access in East Africa. Additionally, the group has historically engaged in life science venture investments through its European division, which rebranded as Granitor in 2022. Its activities span pharmaceutical manufacturing, medical supply distribution, and healthcare infrastructure development. The company operates state-of-the-art manufacturing facilities that adhere to international standards to serve both domestic and regional markets.